Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

QQQJ

Invesco NASDAQ Next Gen 100 ETF (QQQJ)

Rating:68Neutral
Price Target:$48.00▲(11.14% Upside)

QQQJ, the Invesco NASDAQ Next Gen 100 ETF, has a solid overall rating that reflects a portfolio led by strong companies like NetApp, Steel Dynamics, Biogen, and United Airlines, which show healthy financial performance, positive earnings sentiment, and in several cases strong momentum or attractive valuations. These strengths are partly offset by weaker names such as Revolution Medicines, which faces ongoing losses and bearish trading trends, and by some holdings with high leverage or valuation concerns, creating risk if market conditions turn. The main risk factor is that several key holdings carry financial or valuation pressures, so the fund’s success depends on these companies continuing to execute well despite those headwinds.

Positive Factors
Strong Year-to-Date PerformanceThe ETF has delivered strong gains so far this year, showing solid momentum for investors.
Leading Holdings Showing Strong ResultsSeveral of the largest positions, especially in health care and technology, have posted strong performance, helping lift the fund overall.
Low Expense RatioThe fund’s relatively low annual fee means more of the investment returns stay in investors’ pockets over time.
Negative Factors
Heavy U.S. ConcentrationWith almost all assets in U.S. companies, the fund is highly sensitive to the U.S. market and offers limited international diversification.
Sector Concentration in Technology and Health CareA large share of the portfolio is in technology and health care stocks, which can increase risk if these sectors face a downturn.
Recent Short-Term WeaknessThe ETF has shown slightly weak performance over the past month, which may signal near-term volatility even though longer-term results are stronger.

QQQJ vs. SPDR S&P 500 ETF (SPY)

-10%0%10%20%30%40%SPY+14.55%QQQJ+22.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
1.17B
Region
North America
Expense Ratio
0.15%
Beta
1.07
Issuer
Invesco
Inception Date
Oct 13, 2020
Dividend Yield
0.76%
Asset Class
Equity
Index Tracked
Nasdaq Next Generation 100 Index

QQQJ Summary

QQQJ is the Invesco NASDAQ Next Gen 100 ETF, which follows the Nasdaq Next Generation 100 Index. It focuses on the “next wave” of NASDAQ companies just below the famous NASDAQ-100, with a mix of technology, health care, and consumer businesses. Well-known holdings include eBay and Biogen. Investors might consider QQQJ if they want growth potential from emerging leaders while still getting diversification across many sectors. A key risk is that these growth-focused stocks can be more volatile, so the ETF’s value can go up and down sharply with changes in the market.

How much will it cost me?

This ETF has an expense ratio of 0.15%, which means you’ll pay about $1.50 per year for every $1,000 invested. That cost is slightly lower than the average stock ETF because it’s passively managed and simply tracks the Nasdaq Next Generation 100 Index instead of paying managers to pick individual stocks.

What would affect this ETF?

QQQJ could benefit if U.S. economic growth stays solid, technology and health care innovation remains strong, and investor interest in fast-growing NASDAQ companies like Natera, eBay, and Atlassian increases, especially in a stable or falling interest rate environment. On the other hand, higher interest rates, tighter regulations on tech or health care, or a downturn in U.S. growth and consumer spending could hurt many of its key sectors and top holdings, making the ETF more volatile.

QQQJ Top 10 Holdings

QQQJ is leaning into U.S. innovation, with rising names like Okta, NetApp, and Illumina helping power the fund as demand for cloud, cybersecurity, and genomic tools picks up. Natera and Biogen add more health-care punch, keeping performance on a generally upward track. On the flip side, Revolution Medicines has been lagging, and Kimberly-Clark looks more defensive, occasionally acting like a brake on this growth-heavy mix. Overall, the ETF is clearly tilted toward tech and health care, with a mostly U.S.-focused roster of next-gen contenders.

QQQJ top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
EBAYEBAYeBay2.77%$32.12M$53.08B43.22%70Outperform
NTRANTRANatera2.37%$27.45M$46.27B59.01%73Outperform
RVMDRVMDRevolution Medicines1.90%$22.04M$37.27B167.61%52Neutral
UALUALUnited Airlines Holdings1.83%$21.18M$35.51B12.49%74Outperform
BIIBBIIBBiogen1.93%$22.35M$37.46B53.83%74Outperform
MDLNMDLNMedline1.78%$20.67M$51.93B-3.73%――
KMBKMBKimberly Clark1.87%$21.72M$67.15B4.77%63Neutral
NTAPNTAPNetApp1.83%$21.25M$35.62B65.48%76Outperform
STLDSTLDSteel Dynamics1.69%$19.63M$32.63B48.41%76Outperform
IL:ESLTIL:ESLTElbit Systems1.70%$19.75MILS 107.06B48.23%73Outperform

QQQJ Technical Analysis

Technical Analysis SentimentNegative
Last Price43.19

Price Trends

50DMA44.15Negative
100DMA44.53Negative
200DMA42.16Positive

Market Momentum

MACD-0.24Positive
RSI44.70Neutral
STOCH60.52Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QQQJ, the sentiment is Negative. The current price of 43.19 is below the 20-day moving average (MA) of 43.94, below the 50-day MA of 44.15, and above the 200-day MA of 42.16, indicating a neutral trend. The MACD of -0.24 indicates Positive momentum. The RSI at 44.70 is Neutral, neither overbought nor oversold. The STOCH value of 60.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for QQQJ.

QQQJ Peer Comparison

Comparison Results

QQQJ against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
QQQJQQQJ$43.19$48.00(11.14% Upside)$1.17B0.15%68Neutral
VONEVONE$341.41$424.69(24.39% Upside)$9.54B0.06%73Outperform
TCAFTCAF$43.18$53.10(22.97% Upside)$9.24B0.31%69Neutral
FELCFELC$42.62$51.21(20.15% Upside)$9.05B0.18%73Outperform
QYLDQYLD$17.72$23.12(30.49% Upside)$8.24B0.60%73Outperform
FTCSFTCS$104.88$110.76(5.61% Upside)$8.05B0.53%74Outperform

Performance Comparison

0%10%20%30%QQQJVONETCAFFELCQYLDFTCSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
QQQJ and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
QQQJInvesco NASDAQ Next Gen 100 ETF43.197.7621.91%
VONEVanguard Russell 1000 ETF341.4143.4914.60%
TCAFT. Rowe Price Capital Appreciation Equity ETF43.185.2513.84%
FELCFidelity Enhanced Large Cap Core ETF42.625.8615.93%
QYLDGlobal X NASDAQ 100 Covered Call ETF17.722.3014.89%
FTCSFirst Trust Capital Strength ETF104.8814.9516.62%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.